Waltham - The Massachusetts Medical Society, publisher of the
New England Journal of Medicine, today named Eric J. Rubin, MD, PhD, the new editor-in-chief of the
Journal and NEJM Group. Dr. Rubin is chair of the Harvard T.H.
Chan School of Public Health Department of Immunology and Infectious
Diseases and the Irene Heinz Given Professor of Immunology and
Infectious Diseases. The selection of Dr. Rubin was made
after a worldwide search conducted by an international search
committee. He plans to start in September.
“Dr. Rubin is a recognized and respected leader
in the field of infectious disease, where he is known for his
groundbreaking tuberculosis research and his personal dedication to
often neglected populations of patients,” said Maryanne C.
Bombaugh, MD, president of the Massachusetts Medical Society. “We are
thrilled that he will lead the
Journal and NEJM Group.”
Dr. Rubin
began his research work at Harvard College, where he earned a
bachelor’s degree in biochemical sciences in 1980. He later earned MD
and PhD degrees at Tufts
University in 1990 and completed his post-graduate training at
Massachusetts General Hospital. He is the Irene Heinz Given endowed
professor and chair (since 2018) of the Department of Immunology and
Infectious Diseases at the Harvard T.H. Chan School of Public
Health, with additional appointments at Brigham & Women’s Hospital
and Harvard Medical School. He is also a Senior Associate Member of the
Broad Institute.
“All those associated with the
Journal truly believe that they are stewards of a public trust and that the
Journal has an obligation to rigorously evaluate and impartially
present the most important findings in medicine and help translate them
into practice,” said Dr. Rubin. “I look forward to continuing to uphold
the standard of excellence for which the
Journal is known.”
An
author of 147 scientific articles, Dr. Rubin has been an Associate Editor of the
New England Journal of Medicine since 2012. He also has served as an editor or editorial board member of the journals
Tuberculosis, Current Opinion in Microbiology, PLoS Pathogens,
and mBio. Dr. Rubin was born in Brockton, Mass., and lives in the Boston area.
Dr. Rubin succeeds Jeffrey M. Drazen, MD, who has been the editor-in-chief of the
New England Journal of Medicine since 2000. Dr. Drazen led the Journal
through the publication of many landmark studies and developed policies
that led to more transparency in scientific publishing. Dr. Drazen also
oversaw the development of NEJM
Knowledge+, NEJM
Catalyst, NEJM
Resident 360, and NEJM
医学前沿.
“Dr. Rubin’s established reputation for both patient care and training the next generation of clinicians is world renowned,”
said Lois Cornell, Executive Vice President of the Massachusetts Medical Society. “With Dr. Rubin as editor-in-chief of the
Journal and NEJM Group, we look forward to continuing our mission of excellence in medical research and education.”
About the Massachusetts Medical Society
The Massachusetts
Medical Society (MMS) is the statewide professional
association for physicians and medical students, supporting 25,000
members. We are dedicated to educating and advocating for the physicians
of Massachusetts and patients locally and nationally.
A leadership voice in health care, the MMS contributes physician and
patient perspectives to influence health-related legislation at the
state and federal levels, works in support of public health, provides
expert advice on physician practice management, and
addresses issues of physician well-being. Under the auspices of NEJM
Group, the MMS extends our mission globally by advancing medical knowledge from research to patient care through the New England Journal of Medicine, NEJM Catalyst, NEJM
医学前沿,and
NEJM Journal Watch family of specialty publications, and through our
education products for health care professionals: NEJM Knowledge+, NEJM
Resident 360, and our accredited and comprehensive continuing
medical education programs.
